(ACRS) Aclaris Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Aclaris Therapeutics | (ACRS) share price targets
Complete technical analysis of Aclaris Therapeutics (ACRS) by charts plus indicators, forecast predictions and share price targets for Aclaris Therapeutics (ACRS)
Aclaris Therapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2024-05-17 View latest technical analysis
10 day averaged volume of Aclaris Therapeutics is 655256
| Date | Daily Closing Price | Open | High | Low | Volume |
| 17 Fri May 2024 | 1.19 | 1.20 | 1.20 | 1.15 | 0.681 times |
| 16 Thu May 2024 | 1.18 | 1.18 | 1.19 | 1.17 | 0.617 times |
| 15 Wed May 2024 | 1.18 | 1.20 | 1.21 | 1.17 | 0.961 times |
| 14 Tue May 2024 | 1.18 | 1.19 | 1.24 | 1.17 | 0.963 times |
| 13 Mon May 2024 | 1.18 | 1.17 | 1.21 | 1.14 | 1.043 times |
| 10 Fri May 2024 | 1.17 | 1.24 | 1.26 | 1.17 | 0.759 times |
| 09 Thu May 2024 | 1.23 | 1.22 | 1.25 | 1.20 | 0.631 times |
| 08 Wed May 2024 | 1.22 | 1.25 | 1.35 | 1.20 | 1.883 times |
| 07 Tue May 2024 | 1.34 | 1.30 | 1.36 | 1.28 | 1.125 times |
| 06 Mon May 2024 | 1.31 | 1.40 | 1.40 | 1.26 | 0.964 times |
My analysis of stock is bearish for shortterm, but trade for tomorrow is selective. Take a sell trade only if stock stays below 1.2, but if it comes above 1.2, then a intra day buy could be more profitable.
If you take a sell trade below 1.2, then use 1.2 as stoploss and 1.1 as target. However if you take a buy trade in stock , then use 1.2 as stoploss and 1.23 as target.
Share price targets for Aclaris Therapeutics (ACRS)
| Target Type | Value |
| Downside Target | 0.86 |
| Downside Target | 1.05 |
| Downside Target | 1.11 |
| Downside Target | 1.14 |
| Downside Target | 1.17 |
| Upside Target | 1.21 |
| Upside Target | 1.24 |
| Upside Target | 1.30 |
| Upside Target | 1.32 |
| Upside Target | 1.37 |
| Upside Target | 1.40 |
| Upside Target | 1.51 |
Intraday share price targets for Aclaris Therapeutics (ACRS)
| Target Type | Value |
| Downside Intraday Target | 1.14 |
| Downside Intraday Target | 1.09 |
| Upside Intraday Target | 1.24 |
| Upside Intraday Target | 1.29 |
| Downside Intraday Target | 1.19 |
Weekly technical analysis of Aclaris Therapeutics (ACRS)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 17 Fri May 2024 | 1.19 | 1.17 | 1.24 | 1.14 | 0.796 times |
| 10 Fri May 2024 | 1.17 | 1.40 | 1.40 | 1.17 | 0.853 times |
| 03 Fri May 2024 | 1.36 | 1.20 | 1.40 | 1.18 | 0.856 times |
| 26 Fri Apr 2024 | 1.20 | 1.24 | 1.25 | 1.14 | 1.361 times |
| 19 Fri Apr 2024 | 1.24 | 1.22 | 1.30 | 1.21 | 1.149 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Aclaris Therapeutics (ACRS)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 17 Fri May 2024 | 1.19 | 1.21 | 1.40 | 1.14 | 0.54 times |
| 30 Tue Apr 2024 | 1.21 | 1.26 | 1.32 | 1.14 | 0.765 times |
| 28 Thu Mar 2024 | 1.24 | 1.21 | 1.51 | 1.11 | 0.722 times |
| 29 Thu Feb 2024 | 1.19 | 1.18 | 1.37 | 1.05 | 0.506 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Aclaris Therapeutics (ACRS)
Price action analysis of Aclaris Therapeutics ( (ACRS) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Aclaris Therapeutics ( (ACRS) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Aclaris Therapeutics ( (ACRS) ) based on a short to mid term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Aclaris Therapeutics ( (ACRS) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Aclaris Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Aclaris Therapeutics in short term and the sell signal is strong.
Aclaris Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a SELL signal for Aclaris Therapeutics in short term
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Aclaris Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.22 and Aclaris Therapeutics (ACRS) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Aclaris Therapeutics (ACRS) stock. Volume based technical analysis of Aclaris Therapeutics (ACRS) stock is negative.
Aclaris Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Aclaris Therapeutics ( (ACRS) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Aclaris Therapeutics ( (ACRS) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Aclaris Therapeutics ( (ACRS) ) based on a short to mid term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Aclaris Therapeutics ( (ACRS) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Aclaris Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Aclaris Therapeutics in short term and the sell signal is strong.
Aclaris Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a SELL signal for Aclaris Therapeutics in short term
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Aclaris Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.22 and Aclaris Therapeutics (ACRS) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Aclaris Therapeutics (ACRS) stock. Volume based technical analysis of Aclaris Therapeutics (ACRS) stock is negative.
Aclaris Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.